Fund: ISHUSPHA
iShares U.S. Pharmaceuticals ETF (dis) | |
US4642888360 | |
01-05-2006 | |
Equity | |
Equity Sectors - Health Care | |
BlackRock iShares | |
BlackRock Fund Advisors | |
USD | |
1,000 | |
5% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | -4.12% | 0.88% | 9.93% | 4.94% | 5.48% | 1.93% | 5.46% | 3.57% | 4.11% | N/A | |
Priemerná výkonnosť (36 meraní) | 0.46% | 3.83% | 6.12% | 4.22% | 3.14% | ||||||
Volatilita od priemernej výkonnosti | 6.70% | 15.96% | 4.73% | 2.67% | 2.35% |
Long | Short | Net | |
---|---|---|---|
Stock | 99.84% | 99.84% | |
Bond | |||
Other | |||
Cash | 0.20% | 0.05% | 0.16% |
Aktíva | 6,588 mil. |
Počet akcíí | 34 |
Počet dlhopisov | 0 |
Priebež. popl. | |
z toho Mng. popl. | 0.40 |
Výk. prémia | |
Trans. popl. |
Dividenda | 1.100 |
Dividendový výnos | 1.72% |
Rozhodný dátum | 21-03-2024 |
Frekvencia výplaty | štvrťročne |
Giant | 50.26% |
Large | 13.31% |
Medium | 13.26% |
Small | 16.79% |
Micro | 6.23% |
P/E | 13.90% |
P/BV | 3.41% |
Healthcare | 99.84% |
Derivatives | 0.16 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
United States | 99.84% |
Canada | |
Latin America | |
United Kingdom | |
Eurozone | |
Europe - ex Euro | |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 99.84% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Eli Lilly and Co | Healthcare | 23.04% | Johnson & Johnson | Healthcare | 22.39% |
Merck & Co Inc | Healthcare | 4.83% | Pfizer Inc | Healthcare | 4.59% |
Royalty Pharma PLC Class A | Healthcare | 4.52% | Viatris Inc | Healthcare | 4.51% |
Bristol-Myers Squibb Co | Healthcare | 4.51% | Catalent Inc | Healthcare | 4.23% |
Zoetis Inc Class A | Healthcare | 4.22% | Elanco Animal Health Inc | Healthcare | 3.14% |